-
Dual targeting of BCMA and GPRC5D with the trispecific antibody ramantamig addresses antigenic heterogeneity in myeloma
O'Neill, C., Broekmans, M. E. C., Korst, C. L. B. M., Krevvata, M., Dal Collo, G., Groen, R. W., Li, B., Baglio, S. R., Philippar, U., Pillarisetti, K., Zweegman, S., Vishwamitra, D., Mutis, T. & van de Donk, N. W. C. J., Oct 2026, In: HemaSphere. 10, 10, p. e70487 e70487.Research output: Contribution to Journal › Article › Academic › peer-review
-
Monocyte-mediated metabolic rewiring via CD31-CD38 interactions promotes growth and drug-resistance in multiple myeloma
Raoof, R., Dal Collo, G., Simon-Molas, H., Tzortzi, P., Kulaj, K., Demirez, E. N., Massaro, C., Poels, R., Korst, C. L. B. M., O'Neill, C. A., Bruins, W. S. C., Broekmans, M. E. C., Behradkia, P., Krevvata, M., Zweegman, S., Kater, A. P., Baglio, S. R., Mutis, T. & van de Donk, N. W. C. J., Apr 2026, In: HemaSphere. 10, 4, p. e70358 e70358.Research output: Contribution to Journal › Article › Academic › peer-review
-
Pharmacokinetic and pharmacodynamic evaluation of alternative pomalidomide dosing regimens in the treatment of multiple myeloma
Seefat, M. R., Cucchi, D. G. J., van Boven, L., Durdu-Rayman, N., Groen, K., Levin, M. D., de Heer, K., de Valk, B., Wester, R., van der Spek, E., Rentenaar, R., Korst, C. L. B. M., Quik, M., O'Neill, C. A., Tzortzi, P., Smits, F., Mathot, R., Heerma van Voss, M. R., van de Donk, N. W. C. J. & Mutis, T. & 2 others, , 2025, (E-pub ahead of print) In: British Journal of Haematology.Research output: Contribution to Journal › Comment / Letter to the editor › Academic
- All publications
